Julia Katharina Schwarze

Laboratory of Molecular and Medical Oncology
UZB Physician, Internal medicine - endocrinology
Academic, Clinical sciences
Faculty of Medicine and Pharmacy

Laarbeeklaan 101
1090 Jette
Belgium
Laarbeeklaan 101
1090 Brussels
Belgium
Pleinlaan 2
1050 Brussel
Belgium

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Julia Katharina Schwarze is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

143 Citations
6 h-Index
15 Article
12 Meeting abstract (Journal)
11 Poster
4 Meeting abstract (Book)
More
- 1 Unpublished abstract
- 1 Scientific review

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab
Awada, G., Jansen, Y., Schwarze, J. K., Tijtgat, J., Hellinckx, L., Gondry, O., Vermeulen, S., Warren, S., Schats, K., van Dam, P-J., Kockx, M., Keyaerts, M., Everaert, H., Seremet, T., Rogiers, A. & Neyns, B., 2 Jan 2021, In : Cancers. 13, 2, p. 1-18 18 p., 168.
Research output: Contribution to journal › Article
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
Van Damme, H., Dombrecht, B., Kiss, M., Roose, H., Allen, E., Van Overmeire, E., Kancheva, D., Martens, L., Murgaski, A., Bardet, P., Blancke, G., Jans, M., Bolli, E., Martins, M. S., Elkrim, Y., Dooley, J., Boon, L., Schwarze, J. K., Tacke, F., Movahedi, K. & 9 others, Vandamme, N., Neyns, B., Ocak, S., Scheyltjens, I., Vereecke, L., Nana, F. A., Merchiers, P., Laoui, D. & Van Ginderachter, J. A., Feb 2021, In : Journal for immunotherapy of cancer. 9, 2, 16 p., e001749.
Research output: Contribution to journal › Article
Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse
Jansen, Y. J. L., Willekens, I., Seremet, T., Awada, G., Schwarze, J. K., De Mey, J., Brussaard, C. & Neyns, B., 25 Jan 2021, In : Cancers. 13, 3, p. 1-13 13 p., 442.
Research output: Contribution to journal › Article
65MO A phase I clinical trial on intratumoural (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma
Schwarze, J. K., Bertels, C., Awada, G., Tijtgat, J., Tuyaerts, S., Cras, L., Vaeyens, F., Vanbinst, A-M., Everaert, H., Michotte, A., Caljon, B., Olsen, C., Janssen, T., Van Dooren, S., Forsyth, R., Duerinck, J. & Neyns, B., Dec 2020, In : Annals of Oncology. 31, S7, p. S1443-S1443
Research output: Contribution to journal › Meeting abstract (Journal)
An atypical sarcoid-like reaction during anti-protein death 1 treatment in a patient with metastatic melanoma
Keukeleire, S. D., Schwarze, J., Awada, G., Everaert, H., Van Binst, A. M., Cras, L., Neyns, B. & Aspeslagh, S., 2020, In : Melanoma Research. 30, 5, p. 524-527 4 p.
Research output: Contribution to journal › Article

Best Poster Award
Gil Awada (Recipient), Ibrahim Özdemir (Recipient), Julia Katharina Schwarze (Recipient), Emma Daeninck (Recipient), Odrade Gondry (Recipient), Yanina Jansen (Recipient), Teofila Seremet (Recipient), Marleen Keyaerts (Recipient), Hendrik Everaert (Recipient) & Bart Neyns (Recipient), 15 Dec 2018
Prize: Prize (including medals and awards)
Oral presentation 3rd prize
Julia Katharina Schwarze (Recipient), 7 Feb 2020
Prize: Prize (including medals and awards)

2 Talk or presentation at a conference
1 Talk or presentation at a workshop/seminar

A phase I clinical trial on intratumoral (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma
Julia Katharina Schwarze (Speaker), Anne Vanbinst (Contributor)
2020 → …
Activity: Talk or presentation › Talk or presentation at a conference
Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab
Gil Awada (Speaker), Ibrahim Özdemir (Contributor), Julia Katharina Schwarze (Contributor), Emma Daeninck (Contributor), Odrade Gondry (Contributor), Yanina Jansen (Contributor), Teofila Seremet (Contributor), Marleen Keyaerts (Contributor), Hendrik Everaert (Contributor), Bart Neyns (Contributor)
14 Dec 2018
Activity: Talk or presentation › Talk or presentation at a conference
Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab
Odrade Gondry (Speaker), Ibrahim Özdemir (Contributor), Yanina Jansen (Contributor), Gil Awada (Contributor), Julia Katharina Schwarze (Contributor), Teofila Seremet (Contributor), Hendrik Everaert (Contributor), Bart Neyns (Contributor), Marleen Keyaerts (Contributor)
19 Oct 2018
Activity: Talk or presentation › Talk or presentation at a workshop/seminar